Whole-Body Positron Emission Tomography/Computed Tomography Imaging and Staging of Orbital Lymphoma
- 31 October 2006
- journal article
- case report
- Published by Elsevier in Ophthalmology
- Vol. 113 (10) , 1854-1858
- https://doi.org/10.1016/j.ophtha.2006.04.029
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Comparison between 2-deoxy-2-[18F]fluoro-D-Glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphomaMolecular Imaging & Biology, 2004
- Non-Hodgkin Lymphoma and Hodgkin Disease: Coregistered FDG PET and CT at Staging and Restaging—Do We Need Contrast-enhanced CT?Radiology, 2004
- Whole body PET/CT imaging for detection of metastatic choroidal melanomaBritish Journal of Ophthalmology, 2004
- The utility of 2-deoxy-2-6F9fluoro-D-glucose-positron emission tomography and combined positron emission tomography and computed tomography in lymphoma and melanomaMolecular Imaging & Biology, 2004
- FDG PET and PET/CT Imaging in Lymphoma and MelanomaThe Cancer Journal, 2004
- PET–CT of Extranodal LymphomaAmerican Journal of Roentgenology, 2004
- FDG-PET/CT in re-staging of patients with lymphomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Prognostic value of positron emission tomography in the evaluation of post‐treatment residual mass in patients with Hodgkin's disease and non‐Hodgkin's lymphomaBritish Journal of Haematology, 2001
- Ocular adnexal lymphoma---comparison of MALT lymphoma with other histological typesBritish Journal of Ophthalmology, 1999
- Occurrence and prognosis of extranodal lymphomasCancer, 1972